{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-048696","form_type":"8-K","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.449568+00:00","generated_at":"2026-05-16T03:01:15.560998+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Galera Therapeutics enters retention bonus agreement with CAO Joel Sussman for up to $250,000","bullets":["Up to $250,000 in retention bonuses tied to timely completion and filing of reporting obligations.","Retention payments reduce severance payments under existing employment agreement dollar-for-dollar.","Unpaid bonus accelerates if involuntary termination (not for cause) or good reason occurs.","Agreement dated February 6, 2026, with payments tied to specific conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-048696","json":"https://secwatch.observer/filing/0001193125-26-048696.json","markdown":"https://secwatch.observer/filing/0001193125-26-048696.md","text":"https://secwatch.observer/filing/0001193125-26-048696.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/0001193125-26-048696-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312526048696/d892515d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:01:15.560998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}